4
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Low vitamin K1 intake in haemodialysis patients.

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Vitamin K acts as a coenzyme in the γ-carboxylation of vitamin K-dependent proteins, including coagulation factors, osteocalcin, matrix Gla protein (MGP), and the growth arrest-specific 6 (GAS6) protein. Osteocalcin is a key factor for bone matrix formation. MGP is a local inhibitor of soft tissue calcification. GAS6 activity prevents the apoptosis of vascular smooth muscle cells. Few data on vitamin K intake in chronic kidney disease patients and no data in patients on a Mediterranean diet are available. In the present study, we evaluate the dietary intake of vitamin K1 in a cohort of patients undergoing haemodialysis.

          Related collections

          Author and article information

          Journal
          Clin Nutr
          Clinical nutrition (Edinburgh, Scotland)
          Elsevier BV
          1532-1983
          0261-5614
          Apr 2017
          : 36
          : 2
          Affiliations
          [1 ] National Research Council (CNR) - Institute of Clinical Physiology (IFC), Pisa, Italy; Department of Medicine, University of Padua, Italy. Electronic address: dante.lucia@libero.it.
          [2 ] Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
          [3 ] National Research Council (CNR), Neuroscience Institute, Padua, Italy.
          [4 ] Clinical Epidemiology and Physiopathology of Renal Diseases and Hypertension, CNR, Institute of Biomedicine, Reggio Calabria, Calabria, Italy.
          [5 ] Laboratory Medicine Unit, Department of Medicine, University of Padua, Italy.
          [6 ] Department of Medicine (DI-MED), Geriatric Section, University of Padua, Italy.
          [7 ] National Research Council (CNR) - Institute of Clinical Physiology (IFC), Pisa, Italy; Department of Medicine, University of Padua, Italy.
          [8 ] Department of Medicine, Clinica Medica 1, University of Padova, Padova, Italy.
          [9 ] Rheumatology Unit, Department of Medicine, University of Verona, Italy.
          [10 ] Nephrology Unit, ULSS 1 Belluno, Italy.
          [11 ] UOC Nephrology and Dialysis, ULSS 13, Dolo, Italy.
          [12 ] UOC Nephrology and Dialysis, ULSS 2, Feltre, Italy.
          [13 ] Nephrology Unit, University of Padua, Padua, Italy.
          [14 ] Renal Unit, IRCCS Multimedica, Sesto San Giovanni, Milan, Italy.
          [15 ] Nephrology and Dialysis Unit, Ospedale San Carlo Borromeo, ASST Santi Paolo e Carlo, Milan, Italy; Department of Clinical and Biomedical Sciences "Luigi Sacco", University of Milano, Italy.
          Article
          S0261-5614(16)30070-X
          10.1016/j.clnu.2016.04.024
          27234935
          60c90645-aea7-42c5-817d-5d97465e8433
          History

          Dialysis,Diet,Haemodialysis,Menaquinone,Nutrition,Phylloquinone
          Dialysis, Diet, Haemodialysis, Menaquinone, Nutrition, Phylloquinone

          Comments

          Comment on this article